Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)
4 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men'. Together they form a unique fingerprint.